| Next 10 |
Ad
OMER News and Press Omeros Corporation
News | Omeros Corporation (NASDAQ:OMER)
-
2024-11-30 06:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-11-22 12:47:58 ET More on Omeros Omeros Q3 2024 - Updates On OMIDRIA And Narsoplimab Lead To Liquidity Concerns Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript Omeros up 4% as Q3 results beat on EPS Seeking Alpha’s Quant Rating on Omero...
-
Omeros Corporation (Nasdaq: OMER) today announced an update on its progress toward planned resubmission of its biologics license application (“BLA”) for narsoplimab, the company’s first-in-class antibody targeting MASP-2, the effector enzyme of the lectin pathway of complemen...
-
2024-11-17 00:44:24 ET Summary Evaluates Omeros' Q3 2024 performance, referencing the earnings call, 10-Q, and earnings press release. Assesses financial metrics and operational highlights from Q3 2024 to determine the company's health. Reviews strategic initiatives and future...
-
Omeros Corporation (NASDAQ: OMER) is one of today's top gainers. The company's shares have moved 49.88% on the day to $6.28. Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications...
-
2024-11-13 22:22:06 ET Omeros Corporation (OMER) Q3 2024 Earnings Conference Call November 13, 2024 04:30 PM ET Company Participants Jennifer Cook Williams - Investor and Media relations, Cook Williams Communications, Inc. Gregory Demopulos - Chairman and Chief Execu...
-
2024-11-13 17:19:10 ET More on Omeros Seeking Alpha’s Quant Rating on Omeros Historical earnings data for Omeros Financial information for Omeros Read the full article on Seeking Alpha For further details see: Omeros up 4% as Q3 results bea...
-
– Conference Call Today at 4:30 p.m. ET Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2024, which include: Net loss for the third quarter of 2024 was $32.2 millio...
-
2024-11-13 10:00:00 ET Major earnings expected after the bell on Wednesday include: Cisco Systems ( CSCO ) Bionano Genomics ( BNGO ) Nu Holdings Ltd. ( NU ) Vaxart ( VXRT ) Canoo ( GOEV ) Read the full article on Seeking Alpha For furt...
-
Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended September 30, 2024, on Wednesday, November 13, 2024, after the market closes. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Tim...
Stock Information
Get OMER Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-11-30 06:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Omeros Corporation (Nasdaq: OMER) today announced an update on its progress toward planned resubmission of its biologics license application (“BLA”) for narsoplimab, the company’s first-in-class antibody targeting MASP-2, the effector enzyme of the lectin pathway of complemen...
-
Omeros Corporation (NASDAQ: OMER) is one of today's top gainers. The company's shares have moved 49.88% on the day to $6.28. Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications...